Physician profile
Jamie Johnson
NPI 1679887723
$2,498.54
in general payments reported to CMS, 2019-2025
17 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,068 · 2020: $78.32 · 2021: $106 · 2022: $382 · 2023: $149 · 2024: $435 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $864.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,008.73 | 2019 | |
| Abbvie INC. | $382.41 | 2022-2025 | |
| Oyster Point Pharma, INC. | $301.93 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $251.49 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $76.19 | 2021-2022 | |
| Eyevance Pharmaceuticals LLC | $73.80 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $71.62 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $65.11 | 2019-2025 | Rocklatan |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $60.01 | 2020 | |
| Coopervision INC. | $49.87 | 2022-2025 | Myday Contact Lens |
| Thea Pharma INC. | $39.57 | 2022-2023 | Iyuzeh |
| Kala Pharmaceuticals, INC. | $24.11 | 2021 | |
| Sight Sciences, INC. | $23.85 | 2022 | |
| Allergan, INC. | $23.31 | 2021 | |
| Sun Pharmaceutical Industries INC. | $20.56 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $14.26 | 2024 | |
| Shire North American Group INC | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.